S. Korea approves Phase III trial of SK Bioscience's COVID-1

Advertise with us

Advertise with us

QatarDay

Health & Wellbeing

SK Bioscience

S. Korea approves Phase III trial of SK Bioscience's COVID-19 vaccine

REUTERS South Korea gave vaccine developer SK Bioscience (302440.KS) the green light on Tuesday for a Phase III study of its COVID-19 vaccine candidate at a time of vaccine shortages, w...

Desert Falls Live a Little — VIDEO OF THE WEEK

Follow US

categories